
Loading, please wait...

Loading, please wait...

Recent research published in the Journal of Gerontology has unveiled a significant link between glucose metabolism and neurodegeneration. The study explores how specific glucose transporters and receptors influence Huntingtin protein aggregation during the aging process. By utilizing Drosophila models, scientists have identified Glut1 and the G-protein coupled receptor Cirl as critical modulators of proteostasis in Huntington’s disease. These findings provide a fresh perspective on how saccharide signaling pathways manage pathological protein clusters.
The study highlights that Glut1, a major glucose transporter, plays a dual role in protein stability. When researchers knocked down Glut1 expression, they observed a significant increase in Huntingtin protein aggregation as the organisms aged. Conversely, the upregulation of Glut1 appeared to provide a protective effect, reducing the buildup of toxic polyglutamine aggregates. Consequently, maintaining glucose homeostasis appears vital for preventing the protein misfolding characteristic of various neurodegenerative disorders.
Beyond transporters, the research team used RNAi screening to identify several saccharide-binding receptors that affect disease progression. They discovered that the receptor Cirl, which is orthologous to human ADGRL1 and ADGRL2, directly impacts aggregate levels. Specifically, knocking down Cirl led to a reduction in pathogenic Huntingtin protein aggregation. Furthermore, this finding is particularly relevant because it identifies a potential therapeutic target within the adhesion G-protein coupled receptor (aGPCR) family, which is already known for its role in central nervous system development and synaptic health.
These findings suggest that saccharide signaling pathways are not just metabolic regulators but are also central to maintaining proteostasis. For clinicians, this research underscores the emerging importance of metabolic health in managing age-related neurodegeneration. Understanding these pathways could lead to novel interventions that target glucose sensing and transport to mitigate the progression of Huntington’s disease. In addition, the study reinforces the idea that dietary and metabolic factors may directly influence the clearance of toxic proteins in the aging brain.
Glut1 helps regulate glucose levels within cells. Reduced Glut1 levels lead to increased Huntingtin protein aggregation, while higher levels of the transporter help reduce these toxic clusters by improving metabolic efficiency.
Cirl is a saccharide-binding receptor. The study found that reducing Cirl expression decreased the amount of toxic polyglutamine aggregates, identifying it as a potential regulator of neurodegeneration and a target for future drug development.
As we age, the body's ability to maintain protein balance (proteostasis) declines. This study shows that metabolic factors like glucose transporters are key players in preserving this balance during the aging process, potentially slowing cognitive and motor decline.
Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Rai M et al. Regulation of Huntingtin-polyQ Aggregation by Glucose Transporters and Saccharide-binding Receptors during Aging in Drosophila. J Gerontol A Biol Sci Med Sci. 2026 Jun 05. doi: undefined. PMID: 42249710.
He et al. ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis. Diabetologia. 2023 Sep 15. doi: 10.1007/s00125-023-06001-3.
Zeng Y et al. Pathogenic human huntingtin expression causes prolific intramuscular aggregation, leading to nuclear, metabolic, and physiological dysregulation in striated muscle. bioRxiv. 2026 Apr 22. doi: 10.1101/2026.04.20.719674.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new study identifies Glut1 and Cirl receptors as key regulators of huntingtin protein aggregation during aging, linking metabolism to neurodegeneration....
3 months ago

A New York City initiative successfully distributed over 48,000 COVID-19 oral antiviral prescriptions through rapid home delivery in 2022. With 92% delivered within 24 hours, the program safeguarded vulnerable and elderly populations, establishing an equitable framework for emergency drug distribution.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today